First Intestinal Cells Created From ES Cells At Kumamoto University
This article was originally published in PharmAsia News
A research group at Kumamoto University’s School of Medicine has succeeded in creating small intestine cells from ES cells made from fertilized mouse and human eggs, the university announced Feb. 7.
You may also be interested in...
The EU’s massive economic stimulus package, Next Generation EU, includes a wide-ranging health program that aims to make health systems more resilient to future threats by supporting the development and manufacture of affordable new medicines and vaccines as well as measures to prevent drug shortages.
The Swiss major focused almost exclusively on the benefits of the combination of Tecentriq and its TIGIT inhibitor tiragolumab at ASCO but also celebrated the approval of a Tecentriq/Avastin combo for hepatocellular carcinoma.
Mylan first announced plans to develop a biosimilar of the Botox cosmetic and therapeutic brands back in 2018 through an alliance with Revance Therapeutics. More than two years later, a verdict has been reached by the company.